Search results
Healthier Together: Postpartum depression can put new moms, babies at risk
KIRO via Yahoo News· 16 hours ago“The anxiety and depression was something I’ve never felt before. I mean, ...and cried, and cried,”...
A New Treatment Offers Hope to Mothers Battling Postpartum Depression
Denton Record-Chronicle· 3 days agoToday, the term for mothers having anxiety and depression after having a baby is called “postpartum ...
Why is a mother’s mental health so important? A doctor explains
Plus via Yahoo News· 2 days agopostpartum anxiety. It’s normal to feel anxious after becoming a new parent, but it becomes a...
An AI blood test purports to diagnose postpartum depression
Washington Post· 4 days agoPostpartum depression is a leading cause of maternal death, but its diagnosis and treatment is spotty at best, negligent at worst. Now ...
Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN...
The Herald Journal· 2 days agoLipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that dosing of subjects has been completed in the pivotal pharmacokinetic (PK) study designed to support a
Perimenopause may raise risk of one mental health condition by 40%, study finds
CNN.com· 2 days agoIn the years leading up to menopause, a person can experience a multitude of symptoms, including...
Reunion raises over $100M to build a better psychedelic drug
BioPharma Dive via Yahoo Finance· 1 day agoThe funding will help Reunion pay for a mid-stage study testing its most advanced medicine —...
Mental Health Awareness Month kicks off with an urgent report on Black maternal mental health
TheGrio via Yahoo News· 22 hours agoA new report found that maternal mental health is a leading cause of maternal mortality, especially...
Whites Not the Predominant Victims of 'Deaths of Despair'
Medscape· 1 day agoDeaths of despair — defined as midlife deaths from suicide, drug overdose, and alcoholic liver...
HC Wainwright Cuts Sage Therapeutics (NASDAQ:SAGE) Price Target to $25.00
ETF DAILY NEWS· 4 days agoSage Therapeutics (NASDAQ:SAGE – Free Report) had its target price cut by HC Wainwright from $28.00 to $25.00 in a research report sent to investors on Friday morning, Benzinga reports. They ...